Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits

Metabolism: Clinical and Experimental

Volumn 53, Issue 10, 2004, Pages 1315-1321

  Shukla, N ^a   Thompson, C S ^b   Angelini, G D ^a   Mikhailidis, D P ^b   Jeremy, J Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALLOXAN; CALCIMYCIN; CATALASE; COPPER; CYCLIC GMP; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETES MELLITUS; ENZYME ACTIVITY; INJECTION SITE; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; VASODILATATION;

EID: 4544378858     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.05.007     Document Type: Article

References (56)

1. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis Epidemiology, pathophysiology and management. JAMA. 287:2002;2570-2581
2. Ford E.S. Serum copper concentrations and coronary heart disease among US adults. Am J Epidemiol. 151:2000;1182-1188
3. Fox P.L., Mazumder B., Ehrenwald A. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med. 28:2000;1735-1744
4. Zargar A.H., Shah N.A., Masoodi S.R., et al. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J. 74:1998;665-668
5. Cunningham J., Leffell M., Mearkle P., et al. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus Evidence for increased oxidative stress as a variable complication. Metabolism. 44:1995;996-999
6. Walter R.M. Jr, Uriu-Hare J.Y., Olin K.L., et al. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care. 14:1991;1050-1056
7. Daimon M., Susa S., Hasegawa K., et al. Increase in serum ceruloplasmin with aging is not observed in type 2 diabetes. Endocr J. 47:2000;215-219
8. Kojda G., Harrison D. Interaction between NO and reactive oxygen species Pathological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 43:1999;562-571
9. Ammar R.F., Gutterman D.D., Brooks L.A., et al. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc Res. 47:2000;595-601
10. 2 in aorta isolated from chronically streptozotocin-diabetic rats Effects of antioxidant enzymes and enzymes inhibitors. Free Radic Biol Med. 27:1999;16-27
11. Kocak G., Karasu C. Elimination of superoxide/hydrogen peroxide by alpha-lipoic acid mediates the recovery of basal EDRF/NO availability and the reversal of superoxide dismutase-induced relaxation in diabetic rat aorta. Diabetes Obes Metab. 4:2002;69-74
12. Jeremy J.Y., Rowe D., Emsley A.M., et al. Nitric oxide and vascular smooth muscle cell proliferation. Cardiovasc Res. 43:1999;658-665
13. Darley-Usmar V., White R. Disruption of vascular signalling by the reaction of nitric oxide with superoxide Implication for cardiovascular disease. Exp Physiol. 82:1997;305-316
14. Laight D.W., Carrier M.J., Anggard E.E. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res. 47:2000;457-464
15. Chan N.N., Vallance P., Colhoun H.M. Nitric oxide and vascular responses in type I diabetes. Diabetologia. 43:2000;137-147
16. Koppenol W.H. The centennial of the Fenton reaction. Free Radic Biol Med. 15:1993;645-651
17. Koppenol W.H. The Haber-Weiss cycle - 70 years on. Redox Rep. 6:2001;229-234
18. Haber F., Weiss J. Uber die katalyse des hydroperoxydes. Naturwiss. 51:1932;948-959
19. Daimon M., Sugiyama K., Saitoh T., et al. Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care. 23:2000;559-560
20. Thompson C.S., Mumtaz F.H., Khan M.A., et al. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit. Eur J Pharmacol. 425:2001;57-64
21. Shukla N., Thompson C.S., Angelini G.D., et al. Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits. Diabetologia. 45:2002;1325-1331
22. Plane F., Wigmore S., Angelini G.D., et al. Effect of copper on nitric oxide synthase and guanylyl cyclase activity in the rat isolated aorta. Br J Pharmacol. 121:1997;345-350
23. O'Brien S.F., Davidge S.T., Zhang Y., et al. Protection of vascular wall function in insulin-resistant rats from copper oxidative stress. Br J Pharmacol. 133:2001;477-484
24. Chiarugi A., Pitari G.M., Costa R., et al. Effect of prolonged incubation with copper on endothelium-dependent relaxation in rat isolated aorta. Br J Pharmacol. 136:2002;1185-1193
25. Karasu C. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta role of reactive oxygen species. Eur J Pharmacol. 392:2000;163-173
26. Lambert J., Aarsen M., Donker A.J.M., et al. Endothelium dependent and independent vasodilation of large arteries in normoalbuminuric insulin dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;705-711
27. Van Etten R.W., De Koning E.J., Verhaar M.C., et al. Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia. 45:2002;1004-1010
28. Beckman J.A., Goldfine A.B. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation. 103:2001;1618-1623
29. Rosen P., Nawroth P.P., King G., et al. The role of oxidative stress in the onset and progression of diabetes and its complications A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 17:2001;189-212
30. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 190:2000;244-254
31. Tagami S., Kondo T., Yoshida K., et al. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism. 41:1992;1053-1058
32. Kamata K., Kobayashi T. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol. 119:1996;583-589
33. Kobayashi T., Kamata K. Modulation by hydrogen peroxide of noradrenaline-induced contraction in aorta from streptozotocin-induced diabetic rat. Eur J Pharmacol. 441:2002;83-89
34. Arai K., Izuka S., Taniguchi N. Increase in the glycosylated form of erythrocyte Cu-Zn superoxide dismutase in diabetes and close association of the non-enzymatic glycosylation with the enzyme activity. Biochem Biophys Acta. 142:1984;290-296
35. Kawamura N., Ookawara T., Suzuki K., et al. Increased glycated CuZn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 74:1993;1352-1354
36. Ozansoy G., Akin B., Aktan F., et al. Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem. 216:2001;59-63
37. Kocak G., Aktan F., Canbolat O., et al. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab. 13:2000;308-313
38. Voinea M., Georgescu A., Manea A., et al. Superoxide dismutase entrapped-liposomes restore the impaired endothelium-dependent relaxation of resistance arteries in experimental diabetes. Eur J Pharmacol. 484:2004;111-118
39. Zanetti M., Sato J., Katusic Z.S., et al. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol. 280:2001;H2516-H2523
40. Noronha-Dutra A.A., Epperlein M.M., Woolf N. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing. FEBS Lett. 321:1993;59-62
41. Sajithlal G.B., Chithra P., Chandrakasan G. The role of metal-catalyzed oxidation in the formation of advanced glycation end products An in vitro study on collagen. Free Radic Biol Med. 25:1998;265-269
42. Sajithlal G.B., Chithra P., Chandrakasan G. An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen. Mol Cell Biochem. 194:1999;257-263
43. Leonhardt W., Hanefeld M., Muller G., et al. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects. Clin Chim Acta. 254:1996;173-186
44. Emsley A.M., Jeremy J.Y., Gomes G.N., et al. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol. 126:1999;1034-1040
45. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 77:1986;1370-1376
46. Cappelini-Bigazzi M., Ambrosio G., Musci G., et al. Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am J Physiol. 273:1997;H2843-H2849
47. Tapiero H., Townsend D.M., Tew K.D. Trace elements in human physiology and pathology. Copper Biomed Pharmacother. 57:2003;386-398
48. Gutteridge J.M. Copper-phenanthroline-induced site-specific oxygen-radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochem J. 218:1984;983-985
49. Swain J.A., Darley-Usmar V., Gutteridge J.M. Peroxynitrite releases copper from caeruloplasmin Implications for atherosclerosis. FEBS Lett. 342:1994;49-52
50. Kim R.H., Park J.E., Park J.W. Ceruloplasmin enhances DNA damage induced by hydrogen peroxide in vitro. Free Radic Res. 33:2000;81-89
51. Pena M.M.O., Lee J., Thiele D.J. A delicate balance Homeostatic control of copper uptake and distribution. J Nutr. 129:1999;1251-1260
52. Apostolova M.D., Chen S., Chakrabarti S., et al. High-glucose-induced metallothionein expression in endothelial cells An endothelin-mediated mechanism. Am J Physiol. 281:2001;C899-907
53. Fabisiak J.P., Tyurin V.A., Tyurina Y.Y., et al. Redox regulation of copper-metallothionein. Arch Biochem Biophys. 363:1999;171-181
54. Fabisiak J.P., Borisenko G.G., Liu S.X., et al. Redox sensor function of metallothioneins. Methods Enzymol. 353:2002;268-281
55. Eaton J.W., Qian M. Interactions of copper with glycated proteins Possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem. 234:2002;135-142
56. Ito S., Fujita H., Narita T., et al. Urinary copper excretion in type 2 diabetic patients with nephropathy. Nephron. 88:2001;307-312